The Latest in Oncology Practice

Circulating tumor DNA identified by fragment size

November 7, 2018

FDA approves elotuzumab with pom/dex in refractory myeloma

November 7, 2018

Lymphoma & Plasma Cell Disorders

Most nonemergent diagnoses can’t be predicted

November 7, 2018

Mixed Topics

Tumor burden in active surveillance for mRCC may inform treatment decisions

November 6, 2018

CMS pulls back on E/M payment proposal

November 6, 2018

Mixed Topics

Sandoz halts pursuit of U.S. approval for rituximab biosimilar

November 5, 2018

Venetoclax/HMA combo still safe, effective for elderly with AML

November 5, 2018

Leukemia, Myelodysplasia, Transplantation

Guideline authors inconsistently disclose conflicts

November 5, 2018

Practice Management

FDA approves lorlatinib as second line for ALK-positive advanced NSCLC

November 5, 2018

Lung Cancer

Nipple-sparing mastectomy safe in older patients

November 5, 2018

Breast Cancer

Striking racial/ethnic differences seen in RCC features

November 5, 2018

FDA approves sufentanil

November 5, 2018

Mixed Topics

Haploidentical transplantation holds promise in relapsed myeloma

November 3, 2018

Lymphoma & Plasma Cell Disorders

FDA approves second pegfilgrastim biosimilar

November 2, 2018

CMS delays controversial E/M changes in final rule

November 2, 2018

Practice Management